Sinocare Inc. (SHE:300298)
China
· Delayed Price · Currency is CNY 16.58
-0.33 (-1.95%)
Apr 29, 2026, 3:04 PM CST
Sinocare Revenue
Sinocare had revenue of 1.24B CNY in the quarter ending March 31, 2026, with 18.99% growth. This brings the company's revenue in the last twelve months to 4.86B, up 8.63% year-over-year. In the year 2025, Sinocare had annual revenue of 4.66B with 4.87% growth.
Revenue (ttm)
4.86B
Revenue Growth
+8.63%
P/S Ratio
1.93
Revenue / Employee
1.01M
Employees
5,014
Market Cap
9.37B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.66B | 216.21M | 4.87% |
| Dec 31, 2024 | 4.44B | 384.34M | 9.47% |
| Dec 31, 2023 | 4.06B | 106.37M | 2.69% |
| Jan 1, 2023 | 3.95B | 1.59B | 67.38% |
| Jan 1, 2022 | 2.36B | 346.09M | 17.17% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Jan 1, 2018 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Xiangyu Medical Co.,Ltd | 774.78M |
| HOB Biotech Group Corp.,Ltd | 398.40M |
| Sino Medical Sciences Technology | 525.41M |
| Edan Instruments | 2.09B |
| Guangzhou Wondfo Biotech Co.,Ltd | 1.87B |
| INKON Life Technology | 1.97B |
| Shinva Medical Instrument | 9.58B |
| Shenzhen YHLO Biotech | 1.81B |